SCHEMBL24118071

SCHEMBL24118071

C=C(CCNC(=O)c1cccc(C(F)(F)F)c1)CC(=O)Nc1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ RHOC P08134 3/20 0.53
▸ RHOA P61586 3/20 0.53
▸ HDAC3 O15379 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ PTGS1 P23219 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ TP53BP1 Q12888 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ EPHX2 P34913 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CTDSP1 Q9GZU7 1/20 0.47
▸ P2RX1 P51575 1/20 0.47
▸ DDR1 Q08345 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118250 0.82 ALDH1A1 (0.54) POLBALDH1A1RHOCRHOAHDAC3
SCHEMBL30739967 0.79 LMNA (0.78) POLBRHOCRHOAPTGS1LMNA
SCHEMBL24118320 0.78 ALDH1A1 (0.50) POLBALDH1A1RHOCRHOAMEN1
SCHEMBL24117953 0.77 RHOC (0.50) POLBALDH1A1RHOCRHOAHDAC3
SCHEMBL24117941 0.77 POLB (0.51) POLBALDH1A1RHOCRHOALMNA
SCHEMBL24117910 0.74 RHOC (0.45) POLBALDH1A1RHOCRHOAMEN1
SCHEMBL24118257 0.73 KCNQ3 (0.54) ALDH1A1LMNAL3MBTL1MEN1KMT2A
SCHEMBL3514277 0.72 POLB (0.76) POLBALDH1A1HDAC3HDAC1LMNA
SCHEMBL3514281 0.72 POLB (0.76) POLBALDH1A1HDAC3HDAC1LMNA
SCHEMBL13806887 0.71 DDR1 (0.59) POLBALDH1A1HDAC3HDAC1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors MERCK SHARP & DOHME CORP. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors IDO1, IDO2, TPH1 POLB 1950/4885ALDH1A1 144/4885RHOC 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback